Endogenous chemoattractant is
**Core Concept**
The question is testing the student's knowledge of the body's natural mechanisms to attract immune cells to sites of infection or inflammation. This concept is crucial in understanding the pathophysiology of various immune-related disorders.
**Why the Correct Answer is Right**
The correct answer is **Leukotriene B4** (LTB4). LTB4 is a potent endogenous chemoattractant that plays a key role in recruiting neutrophils to the site of inflammation. It acts by binding to its receptor, BLT1, on the surface of neutrophils, triggering a signaling cascade that leads to cell migration and activation. LTB4 is synthesized from arachidonic acid by the enzyme 5-lipoxygenase and is involved in various inflammatory conditions, including asthma and atherosclerosis.
**Why Each Wrong Option is Incorrect**
* **Option A:** Interleukin-8 (IL-8) is a chemoattractant, but it is primarily produced by macrophages and acts on neutrophils, whereas LTB4 is produced by various cells, including neutrophils themselves.
* **Option B:** Tumor necrosis factor-alpha (TNF-alpha) is a cytokine involved in systemic inflammation but is not classified as a chemoattractant.
* **Option C:** Complement component 5a (C5a) is a potent chemoattractant, but it is produced as a result of the complement cascade, whereas LTB4 is produced endogenously through the lipoxygenase pathway.
**Clinical Pearl / High-Yield Fact**
LTB4 is a key player in the pathogenesis of asthma, and its levels are often elevated in patients with severe asthma. Inhibiting LTB4 synthesis or its action may provide a potential therapeutic strategy for treating asthma and other inflammatory conditions.
**Correct Answer: C. Leukotriene B4**